Birtamimab plus standard of care in light-chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial.
Gertz MA, Cohen AD, Comenzo RL, Kastritis E, Landau HJ, Libby EN, Liedtke M, Sanchorawala V, Schönland S, Wechalekar A, Zonder JA, Palladini G, Walling J, Guthrie S, Nie C, Karp C, Jin Y, Kinney GG, Merlini G.
Gertz MA, et al. Among authors: wechalekar a.
Blood. 2023 Oct 5;142(14):1208-1218. doi: 10.1182/blood.2022019406.
Blood. 2023.
PMID: 37366170
Free PMC article.
Clinical Trial.